Results 101 to 110 of about 2,119 (113)
Some of the next articles are maybe not open access.
Neoplasma, 2000
De novo acute myeloid leukemias (AML) patients with normal cytogenetics represent a standard risk cytogenetic group. Erythroblastic and/or megakaryocytic dysplasia (EMD) in diagnostic bone marrow smears of 28 consecutive AML patients with a normal karyotype was studied.
P, Lemez, J, Gáliková, T, Haas
openaire +1 more source
De novo acute myeloid leukemias (AML) patients with normal cytogenetics represent a standard risk cytogenetic group. Erythroblastic and/or megakaryocytic dysplasia (EMD) in diagnostic bone marrow smears of 28 consecutive AML patients with a normal karyotype was studied.
P, Lemez, J, Gáliková, T, Haas
openaire +1 more source
Vnitrni lekarstvi, 2000
Erythroid and/or megakaryocytic dysplasia (EMD) was evaluated in diagnostic bone marrow smears of 37 consecutively treated cases with de novo acute myeloid leukemia (AML) M0-M2 and M4-M5 types and three newly diagnosed cases of refractory anaemia with excess of blasts in transformation.
P, Lemez, J, Gáliková, T, Haas
openaire +1 more source
Erythroid and/or megakaryocytic dysplasia (EMD) was evaluated in diagnostic bone marrow smears of 37 consecutively treated cases with de novo acute myeloid leukemia (AML) M0-M2 and M4-M5 types and three newly diagnosed cases of refractory anaemia with excess of blasts in transformation.
P, Lemez, J, Gáliková, T, Haas
openaire +1 more source
Vnitrni lekarstvi, 2010
Chemotherapy in most patients with AML over 80 years of age is not recommended because their median survival is about 1 month. The aim of our study was to identify patients in this age group who might achieve complete remission with standard dose chemotherapy. We report 9 consecutive patients with de novo AML diagnosed and treated in 1992-2008.
P, Lemez +6 more
openaire +1 more source
Chemotherapy in most patients with AML over 80 years of age is not recommended because their median survival is about 1 month. The aim of our study was to identify patients in this age group who might achieve complete remission with standard dose chemotherapy. We report 9 consecutive patients with de novo AML diagnosed and treated in 1992-2008.
P, Lemez +6 more
openaire +1 more source
CIC‐Rearrangements in Pediatric Acute Erythroid Leukemia/Erythroblastic Sarcoma
Pediatric Blood & CancerAlexandra L. Chang‐Graham +4 more
openaire +1 more source
[Detection of the erythroblast antigen on the blast surface in some forms of acute leukemia].
Problemy gematologii i perelivaniia krovi, 1982L I, Idel'son +4 more
openaire +1 more source

